You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I adult Hodgkin lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      University Hospital of Cologne
    Aug 5, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Completed
    Has Results
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +5 more
    • gemcitabine hydrochloride
    • bendamustine hydrochloride
    • Atlanta, Georgia
    • +1 more
    Oct 21, 2021

    Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Non-Hodgkin Lymphoma
    • San Antonio, Texas
      NEXT Oncology
    Jan 6, 2023

    Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Aug 5, 2022

    Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

    Active, not recruiting
    Has Results
    • Ann Arbor Stage IB Hodgkin Lymphoma
    • +10 more
    • Brentuximab Vedotin
    • Nivolumab
    • Palo Alto, California
    • +8 more
    Jul 20, 2022

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Active, not recruiting
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +16 more
    • 6,8-bis(benzylthio)octanoic acid
    • bendamustine hydrochloride
    • Winston-Salem, North Carolina
    • +1 more
    Apr 8, 2022

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

    Recruiting
    • B-cell Lymphoma
    • +5 more
    • Louisville, Kentucky
      Norton Cancer Institute
    Jan 24, 2023

    Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

    Active, not recruiting
    • Ann Arbor Stage III Non-Hodgkin Lymphoma
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 28, 2023

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
    • Birmingham, United Kingdom
    • +5 more
    Sep 18, 2023

    Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Indolent

    Completed
    Has Results
    • Ann Arbor Stage III Grade 1 Follicular Lymphoma
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 28, 2021

    Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

    Not yet recruiting
    • Advanced Malignancies
    • 1A46 Drug Substance
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 4, 2023

    Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Diffuse Large Cell Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    CD20-positive Non-Hodgkin Lymphoma Trial in China (EX103 injection)

    Recruiting
    • CD20-positive Non-Hodgkin Lymphoma
    • EX103 injection
    • Zhengzhou, Henan, China
    • +3 more
    Aug 28, 2023

    Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed

    Recruiting
    • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Autologous CAR19 T lymphocytes
    • Prague, Czechia
      Institute of Hematology and Blood Transfusion, Czech Republic
    Aug 3, 2022

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin's, Adult
    • (no location specified)
    Aug 4, 2023

    Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

    Suspended
    • Recurrent Aggressive Non-Hodgkin Lymphoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 12, 2023

    CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)

    Recruiting
    • CD20-positive B-cell Non-Hodgkin's Lymphoma
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Apr 6, 2023